ACAD
Acadia Pharmaceuticals Inc. · Healthcare
EVP and CFO Mark C. Schneyer sold $76K of Acadia Pharmaceuticals Inc.
Sold$76,396
$21.79Price
3,506Shares
−5%Stake
What ACAD did after the filing
- The stock from Wed, May 6 open, $22.54
- −4.1%
- S&P 500, same days
- +2.6%
Measured over 30 trading days, to the Jun 18 close.
Traded Mon, May 4. Filed Tue, May 5, 6:00 PM ET, after the close. Returns use the May 6 open and the Jun 18 close. Not investment advice.